Overview

Valproic Acid combinEd With Simvastatin and Gemcitabine/Nab-paclitaxel-based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients.

Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This is a proof-of-concept, Open label, randomized, multicentric, superiority phase-2 study.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute, Naples
Treatments:
Gemcitabine
Paclitaxel
Simvastatin
Valproic Acid